These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 11476767

  • 1. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
    Genazzani AD, Stomati M, Strucchi C, Puccetti S, Luisi S, Genazzani AR.
    Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
    [Abstract] [Full Text] [Related]

  • 2. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
    Genazzani AD, Stomati M, Bernardi F, Pieri M, Rovati L, Genazzani AR.
    Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
    [Abstract] [Full Text] [Related]

  • 3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 4. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z.
    J Endocrinol Invest; 1992 Oct; 15(7):533-8. PubMed ID: 1280287
    [Abstract] [Full Text] [Related]

  • 5. Dehydroepiandrosterone secretion in healthy older men and women: effects of testosterone and growth hormone administration in older men.
    Muniyappa R, Wong KA, Baldwin HL, Sorkin JD, Johnson ML, Bhasin S, Harman SM, Blackman MR.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4445-52. PubMed ID: 16926252
    [Abstract] [Full Text] [Related]

  • 6. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
    Stomati M, Rubino S, Spinetti A, Parrini D, Luisi S, Casarosa E, Petraglia F, Genazzani AR.
    Gynecol Endocrinol; 1999 Feb; 13(1):15-25. PubMed ID: 10368794
    [Abstract] [Full Text] [Related]

  • 7. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F, Palomba S, Colao A, Russo T, Dentico C, Tauchmanovà L, Savastano S, Nappi C, Sultan C, Zullo F, Lombardi G.
    J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
    [Abstract] [Full Text] [Related]

  • 8. Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women.
    Rubino S, Stomati M, Bersi C, Casarosa E, Luisi M, Petraglia F, Genazzani AR.
    Maturitas; 1998 Jan 12; 28(3):251-7. PubMed ID: 9571601
    [Abstract] [Full Text] [Related]

  • 9. Effects of estrogen replacement therapy on dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol responses to exercise in postmenopausal women.
    Johnson LG, Kraemer RR, Haltom R, Kraemer GR, Gaines HE, Castracane VD.
    Fertil Steril; 1997 Nov 12; 68(5):836-43. PubMed ID: 9389812
    [Abstract] [Full Text] [Related]

  • 10. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A, Castelo-Branco C, Tarín JJ.
    Fertil Steril; 1999 Feb 12; 71(2):261-7. PubMed ID: 9988395
    [Abstract] [Full Text] [Related]

  • 11. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.
    Clin Endocrinol (Oxf); 1998 Oct 12; 49(4):421-32. PubMed ID: 9876338
    [Abstract] [Full Text] [Related]

  • 12. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women.
    Papierska L, Rabijewski M, Kasperlik-Załuska A, Zgliczyński W.
    Adv Med Sci; 2012 Jun 01; 57(1):51-7. PubMed ID: 22430044
    [Abstract] [Full Text] [Related]

  • 13. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ, Nolan JJ, Nelson JC, Yen SS.
    J Clin Endocrinol Metab; 1994 Jun 01; 78(6):1360-7. PubMed ID: 7515387
    [Abstract] [Full Text] [Related]

  • 14. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
    Wu X, Sallinen K, Zhou S, Su Y, Pöllänen P, Erkkola R.
    Fertil Steril; 2000 Apr 01; 73(4):730-4. PubMed ID: 10731533
    [Abstract] [Full Text] [Related]

  • 15. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR.
    J Clin Endocrinol Metab; 1996 Aug 01; 81(8):2848-53. PubMed ID: 8768841
    [Abstract] [Full Text] [Related]

  • 16. Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.
    Harrington LB, Marck BT, Wiggins KL, McKnight B, Heckbert SR, Woods NF, LaCroix AZ, Blondon M, Psaty BM, Rosendaal FR, Matsumoto AM, Smith NL.
    J Thromb Haemost; 2017 Jan 01; 15(1):80-90. PubMed ID: 27797446
    [Abstract] [Full Text] [Related]

  • 17. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A, Kaufman JM, Giagulli VA.
    J Clin Endocrinol Metab; 1996 May 01; 81(5):1821-6. PubMed ID: 8626841
    [Abstract] [Full Text] [Related]

  • 18. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N, Evans WS, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2000 Aug 01; 85(8):2649-59. PubMed ID: 10946861
    [Abstract] [Full Text] [Related]

  • 19. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men.
    Villareal DT, Holloszy JO, Kohrt WM.
    Clin Endocrinol (Oxf); 2000 Nov 01; 53(5):561-8. PubMed ID: 11106916
    [Abstract] [Full Text] [Related]

  • 20. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2006 Nov 01; 22(11):627-35. PubMed ID: 17145649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.